XML 97 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation - Additional Information (Details)
$ / shares in Units, $ in Thousands
2 Months Ended 3 Months Ended 12 Months Ended
Nov. 12, 2021
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Mar. 31, 2022
participant
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Nov. 06, 2020
shares
Jan. 02, 2019
shares
Share-based Compensation Arrangement by Share-based Payment Award                  
Accelerated vesting | shares 3,724,000                
Cash received from stock options exercised         $ 858 $ 0      
Series A Convertible Preferred Stock                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Option to conversion outstanding ratio 0.1                
Stock options                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Term of award         10 years        
Maximum total number of common shares for which Stock options may be granted (in shares) | shares               15,640 13,640
Number of shares outstanding (in shares) | shares 11,850 6,921,180 8,049,474   8,049,474 6,921,180 8,683,952    
Share options exchanged (in shares) | shares 6,925,219                
Compensation costs recognized     $ 11,602     $ 1,775      
Cash used to settle award $ 20,597                
Accelerated cost $ 19,953                
Unrecognized compensation cost     $ 22,521   $ 22,521        
Unrecognized compensation cost expected to be recognized over a weighted average period         2 years 8 months 1 day 2 years 11 months 23 days      
Total fair value of common shares vested         $ 2,951 $ 1,349      
Cash received from stock options exercised         858        
Tax benefit from stock options exercised         $ 2,799        
Stock options | Share-based Payment Arrangement, Tranche One                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Percentage of stock options         25.00%        
Stock options | Share-based Payment Arrangement, Tranche Two                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Percentage of stock options         75.00%        
Stock options | 2021 Plan                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Maximum total number of common shares for which Stock options may be granted (in shares) | shares     8,808,435   8,808,435        
RSUs                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Share options exchanged (in shares) | shares 1,291,492                
Compensation costs recognized         $ 618        
Unrecognized compensation cost     $ 278   $ 278        
Unrecognized compensation cost expected to be recognized over a weighted average period         3 months        
Number of shares outstanding (in shares) | shares   0 147,470   147,470 0      
Weighted-average grant date fair value (in dollars per share) | $ / shares   $ 10.98 $ 5.74            
Net settled to cover the required withholding tax upon vesting | shares         64,331        
Award requisite service period         1 year        
Shares granted, trailing closing price per share preceding grant date, period         5 days        
Number of participants | participant       21          
Medical RSUs, incremental share-based compensation expense     $ 187            
Medical RSUs, after forfeitures share-based compensation expense     (11)            
Fair value of the liability-classified medical RSU outstanding     264   $ 264        
Equity-classified medical RSUs, weighted-average grant-date fair value (in dollars per share) | $ / shares         $ 3.56        
Vested (in shares) | shares         0        
RSUs | Share-based Payment Arrangement, Tranche One                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Percentage of stock options         16.67%        
RSUs | Share-based Payment Arrangement, Tranche Two                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Percentage of stock options         83.33%        
Restricted Stock Awards                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Compensation costs recognized         $ 8,284 $ 640      
Number of shares outstanding (in shares) | shares 2,210                
Employees Earnout Shares                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Compensation costs recognized   $ 2,167 $ 7,911            
Unrecognized compensation cost expected to be recognized over a weighted average period         18 days        
Number of shares outstanding (in shares) | shares   1,602,435 1,417,632   1,417,632 1,602,435 0    
Unrecognized compensation expense     $ 552   $ 552        
Vested (in shares) | shares         0        
Employees Earnout Shares | Share-based Payment Arrangement, Tranche One                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Weighted average grant date fair value (in dollars per share) | $ / shares $ 8.35                
Employees Earnout Shares | Share-based Payment Arrangement, Tranche Two                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Weighted average grant date fair value (in dollars per share) | $ / shares $ 6.76                
Restricted Stock Units and Restricted Stock Awards                  
Share-based Compensation Arrangement by Share-based Payment Award                  
Unrecognized compensation cost expected to be recognized over a weighted average period         2 years 4 months 24 days        
Number of shares outstanding (in shares) | shares   1,291,492 2,106,540   2,106,540 1,291,492 1,390,839    
Weighted-average grant date fair value (in dollars per share) | $ / shares         $ 5.74 $ 0      
Unrecognized compensation expense     $ 15,281   $ 15,281        
Vested (in shares) | shares         760,973 0      
Weighted average grant date fair value (in dollars per share) | $ / shares   $ 10.98 $ 7.25   $ 7.25 $ 10.98 $ 10.98